| Susceptibility rate (%) |
||||
|---|---|---|---|---|
| Inducible Enterobacteriaceae* |
Non-inducibleEnterobacteriaceae# |
|||
| <48 h | ≥48 h | <48 h | ≥48 h | |
| Entrapenem | 96 | 94 | 97 | 97 |
| Imipenem | 97 | 96 | 98 | 98 |
| Cefepime | 94 | 87 | 93 | 81 |
| Cefotaxime | 79 | 59 | 93 | 81 |
| Cefoxitin | 27 | 24 | 93 | 81 |
| Ceftazidime | 77 | 57 | 92 | 79 |
| Ampicillin/Sulbactam | 34 | 21 | 62 | 43 |
| Piperacillin/Tazobactam | 34 | 21 | 62 | 43 |
| Amikacin | 99 | 93 | 97 | 95 |
| Ciprofloxacin | 91 | 83 | 84 | 70 |
| Levofloxacin | 93 | 88 | 86 | 72 |
Length of hospitalisation not reported for 6* & 33# isolates.